Skip to main content
Genome&Company logo

Genome&Company — Investor Relations & Filings

Ticker · 314130 ISIN · KR7314130006 KO Manufacturing
Open in API
Filings indexed 427 across all filing types
Latest filing 2019-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 314130

About Genome&Company

http://genomecom.co.kr/

Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides the audit opinion, key financial data, and the name of the accounting firm (태성회계법인). It is a formal disclosure of the audit results for the fiscal year, which falls under the category of standalone audit reports. FY 2018
2019-03-18 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Genome & Company. It outlines the meeting agenda, including the approval of financial statements, appointment of auditors, and other corporate governance matters. This type of document is standard for proxy solicitation and shareholder meeting notifications, which falls under the 'Proxy Solicitation & Information Statement' category.
2019-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding shares by a major shareholder and their special related parties. This falls under the category of Major Shareholding Notification.
2019-03-07 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Genome & Company. It outlines the date, location, and specific agenda items (such as approval of financial statements, appointment of auditors, and stock option grants) for the upcoming Annual General Meeting. This document serves as a proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2019-02-25 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that coincides with other companies' meetings. Since it is a regulatory disclosure regarding meeting logistics and does not contain the actual proxy materials, voting results, or the meeting presentation itself, it falls under the general regulatory filing category.
2019-02-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the resignation of an outside director (Kim Yo-han) from Genome & Company. This falls under the category of changes in the board of directors or senior management.
2019-01-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.